Top compounds associated with response to TIGD7


Feature Type Standardized
Nominal ANOVA
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.067 0.04
mRNA OSI-930 GDSC1000 pan-cancer AAC -0.075 0.04
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.064 0.04
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.12 0.04
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC 0.08 0.04
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.04
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.07 0.04
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.04
mRNA Topotecan CCLE pan-cancer AAC -0.094 0.04
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.078 0.04
Download CSV